Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc

Key Information - The Vanguard Group, Inc. has disclosed its position regarding Avadel Pharmaceuticals plc, indicating ownership of 5,864,733 shares, which represents 6.02% of the company's relevant securities [1][3]. - The disclosure was made on December 26, 2025, with the position held as of December 24, 2025 [1][10]. Interests and Short Positions - Vanguard holds 5,864,733 ordinary shares of Avadel Pharmaceuticals, accounting for 6.02% of the total relevant securities [3]. - There are no short positions or cash-settled derivatives reported in this disclosure [3]. Dealings - On December 24, 2025, Vanguard purchased 752 shares of Avadel Pharmaceuticals at a price of $21.58 per share [7].